These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 11978752)
41. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Stevens TP; Blennow M; Soll RF Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469 [TBL] [Abstract][Full Text] [Related]
42. [Bronchoalveolar lavage with diluted porcine surfactant for alveolar debris removal in newborns treated with mechanical ventilation]. Lista G; Castoldi F; Azzali A; Compagnoni G Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():457-9. PubMed ID: 11424788 [TBL] [Abstract][Full Text] [Related]
43. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381 [TBL] [Abstract][Full Text] [Related]
44. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146 [TBL] [Abstract][Full Text] [Related]
45. Role of interleukin-6, its receptor and soluble gp130 in chronic lung disease of prematurity. Chakraborty M; McGreal EP; Davies PL; Nowell MA; Jones S; Kotecha S Neonatology; 2013; 104(3):161-7. PubMed ID: 23921508 [TBL] [Abstract][Full Text] [Related]
46. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday H; Shah VS Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423 [TBL] [Abstract][Full Text] [Related]
47. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants. Laughon M; Bose C; Allred EN; O'Shea TM; Ehrenkranz RA; Van Marter LJ; Leviton A; Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F114-20. PubMed ID: 20688867 [TBL] [Abstract][Full Text] [Related]
48. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome. Papoff P; Christensen RD; Calhoun DA; Juul SE Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813 [TBL] [Abstract][Full Text] [Related]
49. Repeat surfactant therapy for postsurfactant slump. Katz LA; Klein JM J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122 [TBL] [Abstract][Full Text] [Related]
50. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China]. Network of Northwest Neonatal Professional Collaboration Group Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663 [TBL] [Abstract][Full Text] [Related]
51. Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia. Ohki Y; Kato M; Kimura H; Nako Y; Tokuyama K; Morikawa A Biol Neonate; 2001 Jan; 79(1):34-8. PubMed ID: 11150828 [TBL] [Abstract][Full Text] [Related]
52. [Chronic lung disease in a cohort of children born before the 28th gestational week. Incidence and etiological factors]. Hentze TI; Hansen BM; Jonsbo F; Greisen G Ugeskr Laeger; 2006 Jun; 168(23):2243-7. PubMed ID: 16768977 [TBL] [Abstract][Full Text] [Related]
53. Platelet endothelial cell adhesion molecule-1 and capillary loading in premature infants with and without chronic lung disease. Olsen SL; Thibeault DW; Mabry SM; Norberg M; Truog WE Pediatr Pulmonol; 2002 Apr; 33(4):255-62. PubMed ID: 11921454 [TBL] [Abstract][Full Text] [Related]
55. Management of infants with chronic lung disease of prematurity in Chile. Palomino MA; Morgues M; Martínez F Early Hum Dev; 2005 Feb; 81(2):143-9. PubMed ID: 15748968 [TBL] [Abstract][Full Text] [Related]
56. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML; Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872 [TBL] [Abstract][Full Text] [Related]
57. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. Sharma P; McKay K; Rosenkrantz TS; Hussain N BMC Pediatr; 2004 Jun; 4():9. PubMed ID: 15186501 [TBL] [Abstract][Full Text] [Related]
58. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076 [TBL] [Abstract][Full Text] [Related]
59. [The clinical comparative study of preterm respiratory distress syndrome and transient tachypnea of newborn]. Liu S; Tong X Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):104-8. PubMed ID: 25876684 [TBL] [Abstract][Full Text] [Related]
60. Macrophage phenotype is associated with disease severity in preterm infants with chronic lung disease. Prince LR; Maxwell NC; Gill SK; Dockrell DH; Sabroe I; McGreal EP; Kotecha S; Whyte MK PLoS One; 2014; 9(8):e103059. PubMed ID: 25115925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]